CD20-negative relapse in B-cell lymphoma after treatment with Rituximab [1]

Journal of Clinical Oncology

Volumn 16, Issue 12, 1998, Pages 3916-

  Kinoshita, T ^a   Nagai, H ^a   Murate, T ^a   Saito, H ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; RITUXIMAB;

ADULT; ANTIGEN RECOGNITION; ASTHENIA; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CASE REPORT; CHILL; CLINICAL TRIAL; DRUG SAFETY; FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; URTICARIA;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; LYMPHOMA, B-CELL; MALE; RECURRENCE;

EID: 0032406790     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)